Spanish Agency of Medicines and Medical Devices - Regulatory authority for pharmaceuticals in Spain
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| TAMSULOSINA STADAFARMA 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | Laboratorio Stada S.L. | Medicamento Sujeto A Prescripción Médica | Jun 28, 2024 | Standard |
| APIXABAN PENSA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | Towa Pharmaceutical S.A. | Medicamento Sujeto A Prescripción Médica | Jun 28, 2024 | Standard |
| SOLIKER 30 MG/G GEL | Glenmark Arzneimittel Gmbh | Medicamento Sujeto A Prescripción Médica | Jun 28, 2024 | |
| RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA | Menarini International Operations Luxembourg S.A. | Medicamento Sujeto A Prescripción Médica | Jun 26, 2024 | Standard |
| MANTOMED 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | Medochemie Limited | Diagnóstico Hospitalario | Jun 26, 2024 | Standard |
| RANEXA 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA | Menarini International Operations Luxembourg S.A. | Medicamento Sujeto A Prescripción Médica | Jun 26, 2024 | |
| FRUZAQLA 1 MG CAPSULAS DURAS | Takeda Pharmaceuticals International Ag Ireland Branch | Diagnóstico Hospitalario | Jun 26, 2024 | |
| RANEXA 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA | Menarini International Operations Luxembourg S.A. | Medicamento Sujeto A Prescripción Médica | Jun 26, 2024 | |
| ABRILAR JARABE | Engelhard Arzneimittel Gmbh & Co. Kg | Sin Receta | Jun 26, 2024 | Standard |
| WEZENLA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | Amgen Technology (Ireland) Unlimited Company | Diagnóstico Hospitalario | Jun 26, 2024 | |
| FRUZAQLA 5 MG CAPSULAS DURAS | Takeda Pharmaceuticals International Ag Ireland Branch | Diagnóstico Hospitalario | Jun 26, 2024 | |
| WEZENLA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | Amgen Technology (Ireland) Unlimited Company | Diagnóstico Hospitalario | Jun 26, 2024 | |
| WEZENLA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | Amgen Technology (Ireland) Unlimited Company | Uso Hospitalario | Jun 26, 2024 | |
| RANEXA 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA | Menarini International Operations Luxembourg S.A. | Medicamento Sujeto A Prescripción Médica | Jun 26, 2024 | Standard |
| HIBIWASH 40 MG/ML SOLUCION CUTANEA | Moelnlycke Health Care Ab | Sin Receta | Jun 26, 2024 | Standard |
| TOFIDENCE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | Biogen Netherlands B.V. | Uso Hospitalario | Jun 26, 2024 | Standard |
| MANTOMED 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | Medochemie Limited | Diagnóstico Hospitalario | Jun 26, 2024 | Standard |
| WEZENLA 45 MG SOLUCION INYECTABLE | Amgen Technology (Ireland) Unlimited Company | Diagnóstico Hospitalario | Jun 26, 2024 | |
| DABIDOSE 110 MG CAPSULAS DURAS EFG | Ptr Pharma Consulting, Lda. | Medicamento Sujeto A Prescripción Médica | Jun 24, 2024 | Standard |
| LAMICTAL 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | Laboratoire Glaxosmithkline | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Jun 24, 2024 |
